PAGUE MENOS (PGMN3) Main Indicators
Basic Data - PGMN3
Company | PAGUE MENOS |
Corporate Name | EMPREENDIMENTOS PAGUE MENOS S.A. |
Registration Status | ATIVO |
Issuer Status | FASE OPERACIONAL |
Listing Segment | Novo Mercado |
Activity | Comércio de produtos farmacêuticos. perfumarias e afins. sem manipulação de fórmulas. |
Share | PGMN3 |
Quote Date | 09/18/2024 |
Share Type | ON |
Last Closing | R$ 2.87 |
Quotation Factor | 1 Share |
Financial Volume | R$ 1.52 M |
Last Statement | ITR - 06/30/2024 |
Sector | Saúde |
Subsector | Comércio e Distribuição |
Segment | Medicamentos e Outros Produtos |
Participation Indexes | IBRA, ICON, IGC, IGCT, IGNM, ITAG, SMLL |
Updated 09/19/2024 |
Relative Prices - PGMN3
Price/Earnings | 16.65 |
Price/SBV | 0.63 |
Price/Net Sales | 0.14 |
Price/CFO | 5.76 |
Price/FCF | 8.37 |
Price/Total Assets | 0.19 |
Price/EBIT | 3.28 |
Price/Working Capital | 1.21 |
Price/NCAV | -0.37 |
EV/EBIT | 5.95 |
EV/EBITDA | 2.97 |
EV/Net Sales | 0.26 |
EV/CFO | 10.46 |
EV/FCF | 15.20 |
EV/Total Assets | 0.35 |
Company Market Cap | R$ 1.67 B |
Enterprise Value | R$ 3.03 B |
Current Financial Statement Date | 06/30/2024 |
Current Share Price | R$ 2.87 |
Share Price Date | 09/18/2024 |
Dividend Yield | 10.31% |
Updated 09/19/2024 |
Income Statement - PGMN3
Net Revenue | R$ 11.77 B |
Gross Result | R$ 3.72 B |
EBIT | R$ 509.76 M |
Depreciation and Amortization | - R$ 510.22 M |
EBITDA | R$ 1.02 B |
Net Profit | R$ 100.27 M |
Net Profit/Share | R$ 0.17 |
Updated 08/05/2024 |
Net Revenue | R$ 3.14 B |
Gross Result | R$ 1.02 B |
EBIT | R$ 166.39 M |
Depreciation and Amortization | - R$ 128.62 M |
EBITDA | R$ 295.00 M |
Net Profit | - R$ 83.00 thousand |
Profit/Share | - R$ 0.00 |
Updated 08/05/2024 |
Price and Volume Behavior - PGMN3
Lowest Price 52 weeks | R$ 2.20 |
Highest Price 52 weeks | R$ 3.62 |
Variation 2024 | -18.72% |
Variation 1 year | -14.97% |
Variation 2 years(total) | -36.17% |
Variation 2 years(yearly) | -20.03% |
Variation 3 years(total) | -75.13% |
Variation 3 years(yearly) | -37.06% |
Variation 4 years(total) | -65.16% |
Variation 4 years(yearly) | -23.16% |
Variation 5 years(total) | - |
Variation 5 years(yearly) | - |
Average Daily Volume (3 months) | R$ 2.38 M |
Updated 09/19/2024 |
Returns and Margins - PGMN3
Return on Initial Tangible Capital | 9.37% |
Return on Initial Invested Capital | 9.28% |
Pre-Tax Return on Initial Tangible Capital | 14.19% |
Pre-Tax Return on Initial Invested Capital | 14.06% |
Return on Initial Shareholder´s Equity | 4.47% |
Return on Initial Asset | 1.18% |
Gross Margin | 31.65% |
Net Margin | 0.85% |
EBIT Margin | 4.33% |
EBITDA Margin | 8.67% |
Initial Asset Turnover | 1.39 |
Financial Leverage | 3.25 |
Liabilities/Net Worth | 2.25 |
Net Debt/EBITDA | 1.33 |
Updated 08/05/2024 |
Balance Sheet - PGMN3
Cash and Cash Equivalents | R$ 108.21 M |
Total Assets | R$ 8.58 B |
Short-Term Debt | R$ 138.73 M |
Long-Term Debt | R$ 1.33 B |
Gross Debt | R$ 1.47 B |
Net Debt | R$ 1.36 B |
Shareholder´s Equity | R$ 2.64 B |
Share Book Value | R$ 4.53 |
Common Shares | 581,715,639 |
Preferred Shares | 0 |
Total | 581,715,639 |
Common Shares in Treasury | 406,247 |
Preferred Shares in Treasury | 0 |
Total in Treasury | 406,247 |
Common Shares (Except Treasury) | 581,309,392 |
Preferred Shares (Except Treasury) | 0 |
Total (Except Treasury) | 581,309,392 |
Updated 08/05/2024 |
Cash Flow - PGMN3
Operating Cash Flow | R$ 289.72 M |
Cash Flow from Investments | - R$ 282.59 M |
Financing Cash Flow | - R$ 210.32 M |
Increase (Reduction) in Cash and Equivalents | - R$ 203.19 M |
Updated 08/05/2024 |
Operating Cash Flow | R$ 94.52 M |
Cash Flow from Investments | - R$ 26.24 M |
Financing Cash Flow | - R$ 192.59 M |
Increase (Reduction) in Cash and Equivalents | - R$ 124.31 M |
Updated 08/05/2024 |
Experimental - PGMN3
CAPEX 3 months | - R$ 27.98 M |
Free Cash Flow 3 months | R$ 66.54 M |
CAPEX 12 months | - R$ 90.31 M |
Free Cash Flow 12 months | R$ 199.42 M |
Updated 08/05/2024 |